Harvard Bioscience Inc reiterates FY 2014 guidance


Thursday, 1 May 2014 07:04am EDT 

Harvard Bioscience Inc:Reiterates FY 2014 guidance from Feb. 27, which included revenues to be about same as FY 2013 revenues, which were $105.2 mln.Expects to report FY 2014 non-GAAP income from continuing operations of $0.26 per diluted share.Expects FY 2014 GAAP income from continuing operations of $0.14 per diluted share. 

Company Quote

5.43
0.17 +3.23%
22 May 2015